Human Anti-SARS-CoV-2(2019-nCoV) RBD Antibody

Cat: MO-NAB-00889W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

  • Product Details


Host speciesHuman (Homo sapiens)
Species ReactivitySARS-CoV-2; SARS-COV
SpecificityRecognize SARS-CoV-2 RBD protein
ImmunogenRecombinant SARS-CoV-2 RBD protein
FormatLiquid or Lyophilized
BufferPBS, pH7.5
StorageStore at 4°C: short-term (1-2weeks)
Store at -20°C: long-term and future use

Application Information

ApplicationWB, ELISA
Application NotesWB: 1:1000-2000
Elisa: 1:5000-1:10000


IntroductionSARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), also known as 2019-nCoV (2019 Novel Coronavirus), is a virus that can cause serious illnesses from the common cold. SARS-CoV-2 Spike protein consists of S1 domain and S2 domain. S1 contains a receptor binding domain (RBD) that specifically binds to the receptor angiotensin converting enzyme 2 (ACE2) on target cells. It is believed that the SARS-CoV-2 spike protein (RBD) has potential value for the diagnosis of the virus.
Product OverviewRecombinant anti-SARS-CoV-2 RBD antibody is expressed from XtenCHO
Alternative NamesAnti Spike glycoprotein antibody; Anti 2019-nCoV RBD antibody; Anti 2019-nCoV Spike RBD antibody
For Research Use Only | Not For Clinical Use.
Online Inquiry